Speaker Profile
CoFounder / Chief Communications Officer,
Biography
Tracy Ryan is an award-winning entrepreneur, pediatric cancer advocate and global public speaker that is a driving force behind NKore, a cutting-edge immunotherapy company commercializing a non-toxic, supercharged natural killer (NK) cell therapy for cancer and immune-related diseases. Tracy is a regular speaker on Capitol Hill, shes been an invited guest to the White House 5 times, and shes raised millions in capital for her companies. Tracys journey began when her infant daughter, Sophie, was diagnosed with an incurable brain tumor at 8 ½ months old. Sophie later became patient number 2 and now her incurable brain tumor is crumbling without any adverse effects. With a path set to file for FDA clearance to treat patients in the US in 2026, Tracy
Talk
Engineering Scalable Immunotherapy: A Mission-Driven Path to Market Transformation
Born from a personal catalyst but built for global scale, this talk reveals how our engineered NK-cell platform overcomes the cost, toxicity, and manufacturing barriers limiting todays immunotherapies. We present a de-risked path to commercialization, strong early clinical signals, and a strategy to unlock a multibillion-dollar market with safer, more accessible cancer treatments.
Emerging Therapeutics Showcase:
NKore BioTherapeutics
NKore is advancing a first-in-class preventative immunotherapy platform powered by natural killer (NK) cells, initially targeting a major unmet need in oncology. Our lead candidate, NK101, is designed to eliminate both cancer cells and cancer stem-like cells, while uniquely restoring immune regulatory balance critical for durable disease control.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
